RecruitingNCT06559306
Seltorexant or placebo added to antidepressants for depression with insomnia
About this title
Read the official source — NCT06559306Medication studyAges 18–74Multiple countries
Understand this study
Who could participate?
Listed age limits: 18 years to 74 years.
- Listed locations
- Birmingham and 204 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 25, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 752
- Sponsor
- Janssen Research & Development, LLC
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Argentina, Brazil, ...
- Age range
- From 18 Years to 74 Years
- Official registry ID
- NCT06559306
- Official title
Show the full official title
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-(Milligram) mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients With Major Depressive Disorder With Insomnia Symptoms
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Birmingham, United States · Chandler, United States · Tucson, United States
155 more locations
- Bryant, United States
- Little Rock, United States
- Anaheim, United States
- Colton, United States
- Encino, United States
- Glendale, United States
- Los Alamitos, United States
- Oceanside, United States
- Rancho Cucamonga, United States
- Redlands, United States
- San Jose, United States
- Santa Ana, United States
- Sherman Oaks, United States
- Denver, United States
- Farmington, United States
- Brandon, United States
- Hialeah, United States
- Homestead, United States
- Jacksonville, United States
- Lake City, United States
- Largo, United States
- Miami, United States
- Naples, United States
- North Bay Village, United States
- Orlando, United States
- Saint Augustine, United States
- Tampa, United States
- West Palm Beach, United States
- Winter Park, United States
- Atlanta, United States
- Decatur, United States
- Dunwoody, United States
- Savannah, United States
- Snellville, United States
- Chicago, United States
- Elgin, United States
- Naperville, United States
- Boston, United States
- Watertown, United States
- Mankato, United States
- Las Vegas, United States
- Portsmouth, United States
- Brooklyn, United States
- Buffalo, United States
- Mount Kisco, United States
- New York, United States
- Woodbury, United States
- Hickory, United States
- Avon Lake, United States
- Cincinnati, United States
- Columbus, United States
- Middleburg Heights, United States
- Edmond, United States
- Philadelphia, United States
- Charleston, United States
- Austin, United States
- Bellaire, United States
- Dallas, United States
- Fort Worth, United States
- Garland, United States
- Houston, United States
- Stafford, United States
- Wichita Falls, United States
- Draper, United States
- Everett, United States
- Buenos Aires, Argentina
- Córdoba, Argentina
- La Plata, Argentina
- Rosario, Argentina
- Santiago del Estero, Argentina
- Brasília, Brazil
- Campinas, Brazil
- Criciúma, Brazil
- Natal, Brazil
- Passo Fundo, Brazil
- Porto Alegre, Brazil
- Rio de Janeiro, Brazil
- São Bernardo do Campo, Brazil
- São Paulo, Brazil
- Burgas, Bulgaria
- Plovdiv, Bulgaria
- Sofia, Bulgaria
- Stara Zagora, Bulgaria
- Varna, Bulgaria
- Barranquilla, Colombia
- Bello, Colombia
- Bogotá, Colombia
- Pereira, Colombia
- Brno, Czechia
- Pilsen, Czechia
- Prague, Czechia
- Brescia, Italy
- Catania, Italy
- Chieti, Italy
- Genova, Italy
- Monza, Italy
- Pisa, Italy
- Roma, Italy
- Salerno, Italy
- Siena, Italy
- Mexico City, Mexico
- Monterrey, Mexico
- Nuevo León, Mexico
- San Luis de Potosi, Mexico
- Bydgoszcz, Poland
- Gdansk, Poland
- Gorlice, Poland
- Grudziądz, Poland
- Katowice, Poland
- Leszno, Poland
- Poznan, Poland
- Warsaw, Poland
- Braga, Portugal
- Leiria, Portugal
- Lisbon, Portugal
- Loures, Portugal
- Ponta Delgada, Portugal
- Porto, Portugal
- Touguinho, Portugal
- Bucharest, Romania
- Cluj-Napoca, Romania
- Craiova, Romania
- Focşani, Romania
- Iași, Romania
- Oradea, Romania
- Sânpetru, Romania
- Sibiu, Romania
- Belgrade, Serbia
- Gornja Toponica, Serbia
- Kovin, Serbia
- Novi Kneževac, Serbia
- Bratislava, Slovakia
- Košice, Slovakia
- Liptovský Mikuláš, Slovakia
- Rimavská Sobota, Slovakia
- Svidník, Slovakia
- Vranov nad Topľou, Slovakia
- Barcelona, Spain
- Bilbao, Spain
- Collado Villalba, Spain
- Madrid, Spain
- Torrevieja, Spain
- Lund, Sweden
- Mölndal, Sweden
- Stockholm, Sweden
- Uppsala, Sweden
- Ankara, Türkiye
- Bursa, Türkiye
- Gaziantep, Türkiye
- Istanbul, Türkiye
- Kocaeli, Türkiye
- Samsun, Türkiye
- Trabzon, Türkiye
- Czechia
- Türkiye
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Janssen Research & Development, LLC.
Does this study involve medication?
Yes. The study involves medication, including Seltorexant, Placebo and Selective Serotonin Reuptake Inhibitor (SSRI)/Serotonin-Norepinephrine Reuptake Inhibitor (SNRI).
Who can participate?
Listed age limits: 18 years to 74 years.
Is this study still recruiting?
The registry lists this study as recruiting.
